IDEXX Laboratories, Inc.
IDXX Healthcare Diagnostics & Research
IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.66%, EPS grew 17.2%, free cash flow grew 111.4% and total debt fell 14.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three.
Follow IDXX
IDEXX Laboratories, Inc. (IDXX) Current ratio
IDEXX Laboratories, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 1.2×, down 0.1× from fiscal 2025 (1.2×). Over the past ten years it has ranged from 0.8× (fiscal 2018) to 1.8× (fiscal 2020); the current reading is higher than 64% of that period. That is below the Diagnostics & Research industry median of 2.0× and below the Healthcare sector median of 3.0×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.2× | (6.12%) |
| FY2024 | 1.3× | (16.58%) |
| FY2023 | 1.6× | 76.30% |
| FY2022 | 0.9× | (28.78%) |
| FY2021 | 1.3× | (31.37%) |
| FY2020 | 1.8× | 94.62% |
| FY2019 | 0.9× | 10.35% |
| FY2018 | 0.8× | (12.25%) |
| FY2017 | 1.0× | 6.94% |
| FY2016 | 0.9× | (5.65%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 1.2× | 4.80% |
| Mar 2026 | 1.1× | (9.11%) |
| Dec 2025 | 1.2× | 4.31% |
| Sep 2025 | 1.2× | 6.00% |
| 42 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| NTRA Natera, Inc. compare | 3.0× |
| A Agilent Technologies, Inc. compare | 2.1× |
| WAT Waters Corporation compare | 1.9× |
| ILMN Illumina, Inc. compare | 1.8× |
| LH Labcorp Holdings Inc. compare | 1.8× |
| DGX Quest Diagnostics Incorporated compare | 1.6× |
| IDXX IDEXX Laboratories, Inc. | 1.2× |
| MTD Mettler-Toledo International, Inc. compare | 1.1× |
| IQV IQVIA Holdings Inc. compare | 0.7× |
| Diagnostics & Research industry median | 2.0× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on IDXX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement